ITMCTR2100004956招募中未知
Clinical study of TCM prevention and treatment of diabetic foot based on regional linkage
Shuguang Hospital affillated with Shanghai University of TCM0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 45 至 80（—）
- 性别
- All
入选标准
- •1. Meet the diagnostic criteria for diabetes;
- •2. Comply with the Wagner I-V grading standard of diabetic foot;
- •3. Aged 45 to 80 years;
- •4. The person or his/her guardian agrees to participate in the randomized controlled trial and signs the informed consent.
排除标准
- •1. Other circumstances that the researcher deems unsuitable for inclusion;
- •2. Pregnant or lactating women;
- •3. Patients with diabetic ketosis, ketoacidosis and severe infection within the past 3 months;
- •4. Patients with serious heart, liver, kidney and other complications, or combined with other serious primary diseases and mental illness;
- •5. Neurological and vascular lesions caused by other reasons;
- •6. Those who are allergic to the relevant drugs in the treatment plan and are not suitable for this treatment plan;
- •7. Those who are participating in other clinical trials.
研究者
相似试验
招募中
不适用
Therapeutic Effect of Tangshu Decoction on Prevention and Treatment of High Risk Foot of DiabetesITMCTR2100004934Shuguang Hospital affillated with Shanghai University of TCM
尚未招募
4 期
Clinical Observation for Yi-Wei Xiao-Yu Granule in Treating Chronic Atrophic Gastritischronic atrophic gastritisITMCTR1900002657Chongqing Hospital of Traditional Chinese Medicine
招募中
不适用
Clinical and strategy study on TCM treatments of pulmonary nodules based on state theoryPulmonary NodulesITMCTR2000003903Dongfang Hospital Beijing University of Chinese Medicine
尚未招募
1 期
Research on clinical intervention of TCM Prevention and treatment of MCI based on artificial intelligence big data platform health managementMCIITMCTR2000003810onghua Hospital Affiliated to Shanghai University of traditional Chinese Medicine
尚未招募
不适用
The clinical trial scheme of TCM in improving the clinical benefit rate of stage II HBV-associated hepatocellular carcinoma after combined minimally invasive surgeryhepatitis b-related hepatocellular carcinoma in stage IIITMCTR1900002319the First Affiliated Hospital of Henan University of TCM